-
1دورية أكاديمية
المؤلفون: David G. Alleva, Eline A. Feitsma, Yester F. Janssen, Hendrikus H. Boersma, Thomas M. Lancaster, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Andrea R. Delpero, Melanie M. Scully, Ramya Ragupathy, Sravya Kotha, Jeffrey R. Haworth, Nishit J. Shah, Vidhya Rao, Shashikant Nagre, Shannon E. Ronca, Freedom M. Green, Stephen A. Shaw, Ari Aminetzah, Schelto Kruijff, Maarten Brom, Gooitzen M. van Dam, Todd C. Zion
المصدر: npj Vaccines, Vol 9, Iss 1, Pp 1-12 (2024)
مصطلحات موضوعية: Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2059-0105
-
2دورية أكاديمية
المؤلفون: David G. Alleva, Andrea R. Delpero, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Thomas M. Lancaster, Mark A. Atkinson, Clive H. Wasserfall, Liping Yu, Ramya Ragupathy, Rachel H. Bonami, Todd C. Zion
المصدر: Frontiers in Immunology, Vol 15 (2024)
مصطلحات موضوعية: autoreactive B cell, autoimmunity, type 1 diabetes, Fc-fusion protein, antigen specific immunotherapeutic, insulin autoantigen, Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
-
3
المؤلفون: Andrea R Delpero, Larry Karnes, Shannon E. Ronca, Shashikant Nagre, David G. Alleva, Sarah S Webb, Hanne Andersen Elyard, Allison I Jasa, Thomas M. Lancaster, JoAnn Yee, Sylaja Murikipudi, Vidhya Rao, Frans Sollie, Nishit J Shah, Freedom M Green, Melanie M Scully, Jeffrey R Haworth, Thillainaygam Sathiyaseelan, Emma K Greaves, Ramya Ragupathy, Jeffrey Klein, Todd C. Zion
المصدر: Vaccine
مصطلحات موضوعية: medicine.medical_treatment, PFU, plaque-forming units, Antibodies, Viral, Immunoglobulin G, Neutralization, Mice, PRNT, plaque reduction neutralization test, Infectious disease, ID50, Inhibitory Dilution 50%, SP, Spike Protein, NHP, non-human primate, Immunogenicity, Titer, Infectious Diseases, Spike Glycoprotein, Coronavirus, Vaccines, Subunit, Molecular Medicine, APCs, antigen-presenting cells, Rabbits, EUA, Emergency Use Authorization, Adjuvant, Primates, COVID-19 Vaccines, Recombinant Fusion Proteins, Ag, antigen, MFI, mean fluorescent intensity, Biology, Article, Virus, nAb, neutralizing antibody, Neonatal Fc receptor, PRNT50, maximum dilution with greater than 50% inhibition, Antigen, ACE2, angiotensin converting enzyme-2, medicine, Animals, Fc-fusion, SP/RBD, spike protein receptor binding domain, Pandemic, General Veterinary, General Immunology and Microbiology, Prophylaxis, ELISA, Enzyme Linked Immunosorbent Assay, SARS-CoV-2, Public Health, Environmental and Occupational Health, COVID-19, Antibodies, Neutralizing, Virology, Coronavirus, HCS, Human convalescent serum, OD, optical density, P, passage, biology.protein
-
4Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452
المؤلفون: Yester F. Janssen, Eline A. Feitsma, Hendrikus H. Boersma, David G. Alleva, Thomas M. Lancaster, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Andrea R. Delpero, Melanie M. Scully, Ramya Ragupathy, Sravya Kotha, Jeffrey R. Haworth, Nishit J. Shah, Vidhya Rao, Shashikant Nagre, Shannon E. Ronca, Freedom M. Green, Ari Aminetzah, Frans Sollie, Schelto Kruijff, Maarten Brom, Gooitzen M. van Dam, Todd C. Zion
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: Vaccine
Vaccine, 40(9), 1253-1260. ELSEVIER SCI LTDمصطلحات موضوعية: Adult, History, COVID-19 Vaccines, Polymers and Plastics, Adolescent, HCS, human convalescent serum, Antibodies, Viral, Industrial and Manufacturing Engineering, Article, Young Adult, Clinical Trials, Phase II as Topic, Immunogenicity, Vaccine, ACE2, angiotensin converting enzyme-2, Humans, Business and International Management, Aged, Fc-fusion, SP/RBD, spike protein receptor binding domain, Infectious disease, SAE, serious adverse event, General Veterinary, General Immunology and Microbiology, Pandemic, SP, Spike Protein, Prophylaxis, SARS-CoV-2, ELISA, Enzyme Linked Immunosorbent Assay, Public Health, Environmental and Occupational Health, COVID-19, Middle Aged, AKS-452, Antibodies, Neutralizing, Coronavirus, Infectious Diseases, Immunoglobulin G, Spike Glycoprotein, Coronavirus, Vaccines, Subunit, Molecular Medicine, Vaccine, AE, adverse event
وصف الملف: application/pdf